iShares Biotechnology ETF (IBB) Research

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

Market snapshot

Symbol
IBB
Price
$173.64
Day change
+0.12%
Market cap
$8.1B
52-week range
123.61-179.64
Sector
Financial Services
Industry
Asset Management

Recent news

  • Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC

    Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC.  Many biotech companies are now pursuing a dual-track process: preparing for an IPO while simultaneously engaging with potential acquirers.

  • Biotech Investors Are Tuning Out the MAHA Chaos

    The Food and Drug Administration is still in turmoil, but Wall Street no longer cares.

  • Locking In A Quick Gain In This Biotech ETF Made Room For Better Swing Trades; Here's Why

    Locking in profits while you have them can help avoid downturns.

Peer companies

  • WisdomTree U.S. LargeCap Dividend Fund (DLN)
  • iShares MSCI Taiwan ETF (EWT)
  • iShares International Select Dividend ETF (IDV)
  • iShares S&P Mid-Cap 400 Value ETF (IJJ)
  • iShares S&P Small-Cap 600 Value ETF (IJS)
  • iShares S&P Small-Cap 600 Growth ETF (IJT)
  • iShares Global 100 ETF (IOO)
  • iShares Global Tech ETF (IXN)

Open iShares Biotechnology ETF (IBB) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.